Related Experiment Video
Updated: Oct 20, 2026

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
New MR imaging contrast agents
1Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. jearls@rad.jhu.edu
Abstract:
Many new MR contrast agents are undergoing laboratory development, are in clinical trials, or are being used for routine clinical applications. These agents function by targeting specific receptors that allow the agent to accumulate within the reticuloendothelial system, the hepatobiliary system, or the blood pool. Each agent has unique properties that offer advantages over unenhanced and gadolinium chelate-enhanced MR imaging. Use of these agents, however, requires an understanding of their current and potential clinical indications and inherent limitations. This article reviews the development, evaluation, and clinical application of a number of these agents, including ferumoxides, Mn-DPDP, AMI-227, SHU-555A, Gd-EOB/DTPA, Gd-BOPTA, and MS-325.
Related Concept Videos
Imaging Studies III: Computed Tomography
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Radiological Investigation I: X-ray and CT
Imaging Studies for Cardiovascular System V: CT

